AACR Annual Meeting 2023 AACR 2023: Neoadjuvant Durvalumab Plus Chemotherapy Followed by Adjuvant Durvalumab in Patients With Resectable NSCLC
Breast Cancer ASCO 2024: Predictors of Taxane-Induced Peripheral Neuropathy in Black Women With Early-Stage Breast Cancer